ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $1.2B
- YoY, 2025
- +24.1%
- 5-year CAGR
- +15.5%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $1.2B | +24.1% |
| 2024 | $976M | +22.6% |
| 2023 | $796M | +3.2% |
| 2022 | $771M | +24.2% |
| 2021 | $621M | +5.5% |
| 2020 | $588M | +22.8% |
| 2019 | $479M | +25.3% |
| 2018 | $382M | +91.8% |
| 2017 | $199M | +123.1% |
| 2016 | $89M | — |